Care Health Insurance (CHIL), a subsidiary of Religare Enterprises, has received income-tax demand orders totalling ₹140.20 Crores, including interest, for Assessment Years 2023-24 and 2024-25. The company disputes the computation, expecting a revised demand closer to ₹96 Crores after filing a rectification application and intends to file an appeal.
Why it matters
This tax demand, if upheld, could affect CHIL's financial standing and profitability. Religare Enterprises' consolidated financials may also be impacted by any final liability borne by its subsidiary.
Past Challenges
The Religare group has faced previous regulatory and financial scrutiny. Religare Enterprises and its subsidiary Religare Finvest Limited (RFL) have encountered SEBI proceedings related to alleged fund diversion. Separately, Care Health Insurance was fined ₹1 crore by the IRDAI in December 2025 for lapses in claims settlement, policyholder protection, and corporate governance, including issues with grievance redressal and cybersecurity.
Immediate Impact
CHIL will incur costs for legal consultations and filing the rectification and appeal processes. Management's focus will be divided between this tax dispute and ongoing business operations. The financial health of CHIL could be strained if a significant portion of the demand materialises. Investors will closely monitor the progress of CHIL's applications.
Potential Risks
The main risk lies in the final outcome of the tax demand. Although CHIL anticipates a reduction, the tax authorities' decision is final. Even a reduced ₹96 Crores demand is a substantial sum CHIL must manage. Previous regulatory actions could also affect investor sentiment if they lead to unexpected liabilities.
Market Context
Care Health Insurance operates in a competitive market alongside major players like Star Health and Allied Insurance, Niva Bupa Health Insurance, and Aditya Birla Health Insurance. These companies also navigate complex regulations and financial management.
Performance Snapshot
Religare Enterprises reported consolidated revenue of ₹6,299 crore in FY24, a 30% year-on-year increase. Its insurance arm, CHIL, recorded premium collections of ₹7,022 crore for FY24. CHIL's gross written premium was ₹2,621 crore in Q3 FY26.
What to watch next
- The outcome of CHIL's rectification application with tax authorities.
- The timeline and progress of any subsequent appeal process.
- Further updates from the tax department or CHIL on the final demand.
- Management commentary on the financial impact during upcoming earnings calls.
